{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:02:21Z","timestamp":1774526541294,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maternal drug use during pregnancy is a significant concern. Drug-exposed newborns are often born premature and may suffer from birth defects, neonatal abstinence syndrome and cognitive and developmental delays. Because of this, testing of neonatal specimens is carried out to assess fetal drug exposure during pregnancy. Umbilical cord tissue (UC) and meconium are commonly used specimens for this purpose. However, comprehensive studies comparing drug positivity rates and concentration in the two specimen types are lacking. To this end, 4,036 paired UC and meconium specimens originating from 13 states within the USA were identified, and retrospective analysis of drug positivity rates and drug concentration was performed for 31 analytes in 5 drug classes. Testing for 11-Nor-9-carboxy-tetrahydrocannabinol (THC-COOH) is a separate orderable for UC specimen at our laboratory, so a second data set was created for evaluation of this drug analyte with 2,112 paired UC and meconium specimens originating from 11 states. Testing of UC was performed by semi-quantitative liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS-MS) assays, whereas, for meconium, an immunoassay-based screening preceded LC\u2013MS-MS confirmation tests. Results generated for UC and meconium specimens were therefore compared for a total of 32 drug analytes from 6 drug classes. Drug concentrations for analytes were higher in meconium compared to UC, with the exception of phencyclidine. Despite this, the positivity rates for individual analytes were higher in UC, with the exception of THC-COOH and cocaine. Furthermore, analysis for multidrug positivity revealed that THC-COOH and opioids were the most common multidrug combination detected in both matrices. In conclusion, this study suggests that for most drug compounds, UC was more analytically sensitive to assess neonatal drug exposure by current methodologies. Additionally, by demonstrating that meconium has higher drug concentrations for most compounds, this study sets the stage for developing more sensitive assays in meconium.<\/jats:p>","DOI":"10.1093\/jat\/bkac037","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T07:30:12Z","timestamp":1655364612000},"page":"96-105","source":"Crossref","is-referenced-by-count":11,"title":["Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-0138","authenticated-orcid":false,"given":"Vrajesh","family":"Pandya","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Utah Health , Salt Lake City, UT 84112, USA"},{"name":"ARUP Laboratories , 500 Chipeta Way, Salt Lake City, UT 84108, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chase","family":"Wilker","sequence":"additional","affiliation":[{"name":"ARUP Laboratories , 500 Chipeta Way, Salt Lake City, UT 84108, USA"},{"name":"ARUP Institute for Clinical and Experimental Pathology , 500 Chipeta Way, Salt Lake City, UT 84108, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-5878","authenticated-orcid":false,"given":"Gwendolyn A","family":"McMillin","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah Health , Salt Lake City, UT 84112, USA"},{"name":"ARUP Laboratories , 500 Chipeta Way, Salt Lake City, UT 84108, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/FTD.0000000000000747","article-title":"Drug exposure in newborns: effect of selected drugs prescribed to mothers during pregnancy and lactation","volume":"42","author":"Rentsch","year":"2020","journal-title":"Therapeutic Drug Monitoring"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"e1009","DOI":"10.1542\/peds.2012-3931","article-title":"Prenatal substance abuse: short- and long-term effects on the exposed fetus","volume":"131","author":"Behnke","year":"2013","journal-title":"Pediatrics"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000485","article-title":"Detection of drug-exposed newborns","volume":"40","author":"Wabuyele","year":"2018","journal-title":"Therapeutic Drug Monitoring"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/npp.2014.147","article-title":"Developmental consequences of fetal exposure to drugs: what we know and what we still must learn","volume":"40","author":"Ross","year":"2015","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"2023022112503493600_","article-title":"How States Handle Drug Use During Pregnancy","volume-title":"ProPublica","author":"Miranda","year":"2015"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpeds.2018.09.046","article-title":"Umbilical cord tissue and meconium may not be equivalent for confirming in utero substance exposure","volume":"205","author":"Colby","year":"2019","journal-title":"The Journal of Pediatrics"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.clinbiochem.2017.09.016","article-title":"Method performance and clinical workflow outcomes associated with meconium and umbilical cord toxicology testing","volume":"50","author":"Labardee","year":"2017","journal-title":"Clinical Biochemistry"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.clinbiochem.2017.03.006","article-title":"Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure","volume":"50","author":"Colby","year":"2017","journal-title":"Clinical Biochemistry"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/papr.12814","article-title":"Medication use and pain management in pregnancy: a critical review","volume":"19","author":"Black","year":"2019","journal-title":"Pain Practice"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/FTD.0000000000000181","article-title":"Patterns of drugs and drug metabolites observed in meconium: what do they mean?","volume":"37","author":"McMillin","year":"2015","journal-title":"Therapeutic Drug Monitoring"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jat\/23.6.436","article-title":"Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium","volume":"23","author":"ElSohly","year":"1999","journal-title":"Journal of Analytical Toxicology"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/anatox\/35.1.40","article-title":"Drugs of abuse detection in meconium: a comparison between ELISA and biochip microarray","volume":"35","author":"Marin","year":"2011","journal-title":"Journal of Analytical Toxicology"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jat\/bkt052","article-title":"Detection of in utero marijuana exposure by GC-MS, ultra-sensitive ELISA and LC-TOF-MS using umbilical cord tissue","volume":"37","author":"Chittamma","year":"2013","journal-title":"Journal of Analytical Toxicology"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/FTD.0b013e3182a0d18c","article-title":"Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry","volume":"36","author":"Marin","year":"2014","journal-title":"Therapeutic Drug Monitoring"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jat\/bkaa118","article-title":"Patterns of neonatal co-exposure to gabapentin and commonly abused drugs observed in umbilical cord tissue","volume":"45","author":"Okoye","year":"2021","journal-title":"Journal of Analytical Toxicology"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-8823-5_20","article-title":"Detection of in utero cannabis exposure in umbilical cord tissue by a sensitive liquid chromatography-tandem mass spectrometry method","volume":"1872","author":"Wu","year":"2019","journal-title":"Methods in Molecular Biology (Clifton, N.J.)"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.clinms.2019.01.002","article-title":"Detection of in utero exposure to cannabis in paired umbilical cord tissue and meconium by liquid chromatography-tandem mass spectrometry","volume":"14","author":"Jensen","year":"2019","journal-title":"Clinical Mass Spectrometry"},{"key":"2023022112503493600_","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jat\/bkab077","article-title":"Umbilical cord drug screening in multiple births: experience from a reference laboratory and academic medical center","author":"Nelson","year":"2021","journal-title":"Journal of Analytical Toxicology"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4939-8823-5_18","article-title":"Alternate matrices: meconium, cord tissue, hair, and oral fluid","volume":"1872","author":"Palmer","year":"2019","journal-title":"Methods in Molecular Biology (Clifton, N.J.)"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/951616","article-title":"Drug testing for newborn exposure to illicit substances in pregnancy: pitfalls and pearls","volume":"2011","author":"Farst","year":"2011","journal-title":"International Journal of Pediatrics"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12024-016-9780-2","article-title":"Identifying cases of heroin toxicity where 6-acetylmorphine (6-AM) is not detected by toxicological analyses","volume":"12","author":"Ellis","year":"2016","journal-title":"Forensic Science, Medicine, and Pathology"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/FTD.0b013e3181bb438e","article-title":"Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study","volume":"31","author":"Gray","year":"2009","journal-title":"Therapeutic Drug Monitoring"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000485","article-title":"Detection of drug-exposed newborns","volume":"40","author":"Wabuyele","year":"2018","journal-title":"Therapeutic Drug Monitoring"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/dta.1489","article-title":"Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays","volume":"6","author":"Swortwood","year":"2014","journal-title":"Drug Testing and Analysis"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","DOI":"10.1177\/2374289518811797","article-title":"A difficult challenge for the clinical laboratory: accessing and interpreting manufacturer cross-reactivity data for immunoassays used in urine drug testing","volume":"5","author":"Reschly-Krasowski","year":"2018","journal-title":"Academic Pathology"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2393-14-250","article-title":"Retrospective analysis of the diagnostic yield of newborn drug testing","volume":"14","author":"Wood","year":"2014","journal-title":"BMC Pregnancy and Childbirth"},{"key":"2023022112503493600_","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/clinchem\/41.11.1614","article-title":"False-positive and false-negative rates in meconium drug testing","volume":"41","author":"Moore","year":"1995","journal-title":"Clinical Chemistry"},{"key":"2023022112503493600_","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00961","article-title":"Screening pregnant women and their neonates for illicit drug use: consideration of the integrated technical, medical, ethical, legal, and social issues","volume":"9","author":"Price","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"2023022112503493600_","article-title":"2021 Marijuana Policy Reform Legislation","author":"Marijuana Policy Project","year":"2021"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkac037\/44280761\/bkac037.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/47\/1\/96\/49285223\/bkac037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/47\/1\/96\/49285223\/bkac037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T07:39:24Z","timestamp":1700725164000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/47\/1\/96\/6609045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,6,16]]},"published-print":{"date-parts":[[2023,2,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkac037","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,6,16]]}}}